KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Equity (2018 - 2025)

Historic Return on Equity for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to 0.52%.

  • Amneal Pharmaceuticals' Return on Equity fell 24600.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year decrease of 24600.0%. This contributed to the annual value of 1.65% for FY2024, which is 21300.0% up from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Return on Equity of 0.52% as of Q3 2025, which was down 24600.0% from 0.42% recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Equity ranged from a high of 5.52% in Q1 2024 and a low of 1.62% during Q1 2023
  • In the last 5 years, Amneal Pharmaceuticals' Return on Equity had a median value of 0.0% in 2022 and averaged 0.19%.
  • In the last 5 years, Amneal Pharmaceuticals' Return on Equity skyrocketed by 71400bps in 2024 and then tumbled by -57900bps in 2025.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Return on Equity stood at 0.05% in 2021, then tumbled by -2600bps to 1.35% in 2022, then soared by 58bps to 0.56% in 2023, then soared by 230bps to 0.73% in 2024, then crashed by -171bps to 0.52% in 2025.
  • Its Return on Equity was 0.52% in Q3 2025, compared to 0.42% in Q2 2025 and 0.27% in Q1 2025.